FR2987267B1 - APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES - Google Patents

APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES

Info

Publication number
FR2987267B1
FR2987267B1 FR1200581A FR1200581A FR2987267B1 FR 2987267 B1 FR2987267 B1 FR 2987267B1 FR 1200581 A FR1200581 A FR 1200581A FR 1200581 A FR1200581 A FR 1200581A FR 2987267 B1 FR2987267 B1 FR 2987267B1
Authority
FR
France
Prior art keywords
cacanomanes
modafinil
substitution
treatment
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1200581A
Other languages
French (fr)
Other versions
FR2987267A1 (en
Inventor
Pascal Suplie
Philippe Vivet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debregeas Et Associes Pharma SAS
Original Assignee
Debregeas Et Associes Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1200581A priority Critical patent/FR2987267B1/en
Application filed by Debregeas Et Associes Pharma SAS filed Critical Debregeas Et Associes Pharma SAS
Priority to SG11201405316WA priority patent/SG11201405316WA/en
Priority to BR112014020626A priority patent/BR112014020626A2/en
Priority to PL13715263T priority patent/PL2819655T3/en
Priority to PCT/FR2013/000052 priority patent/WO2013128088A1/en
Priority to NZ628009A priority patent/NZ628009A/en
Priority to KR1020147023180A priority patent/KR101897855B1/en
Priority to IN7831DEN2014 priority patent/IN2014DN07831A/en
Priority to PT137152633T priority patent/PT2819655T/en
Priority to ES13715263.3T priority patent/ES2593276T3/en
Priority to DK13715263.3T priority patent/DK2819655T3/en
Priority to RS20160882A priority patent/RS55238B1/en
Priority to CN201380011342.7A priority patent/CN104159575B/en
Priority to EA201400960A priority patent/EA025692B1/en
Priority to EP13715263.3A priority patent/EP2819655B1/en
Priority to LTEP13715263.3T priority patent/LT2819655T/en
Priority to AU2013224831A priority patent/AU2013224831B2/en
Priority to HUE13715263A priority patent/HUE030737T2/en
Priority to US14/381,896 priority patent/US20150073055A1/en
Priority to UAA201409664A priority patent/UA113301C2/en
Priority to JP2014559270A priority patent/JP6163169B2/en
Priority to MX2014010237A priority patent/MX348222B/en
Priority to CA2863159A priority patent/CA2863159C/en
Priority to SI201330319A priority patent/SI2819655T1/en
Priority to ARP130100596A priority patent/AR090169A1/en
Priority to TW102106817A priority patent/TWI626042B/en
Publication of FR2987267A1 publication Critical patent/FR2987267A1/en
Priority to IL234009A priority patent/IL234009B/en
Priority to ZA2014/05910A priority patent/ZA201405910B/en
Priority to PH12014501837A priority patent/PH12014501837A1/en
Priority to CL2014002203A priority patent/CL2014002203A1/en
Publication of FR2987267B1 publication Critical patent/FR2987267B1/en
Application granted granted Critical
Priority to HRP20161165TT priority patent/HRP20161165T1/en
Priority to SM201600363T priority patent/SMT201600363B/en
Priority to CY20161101079T priority patent/CY1118166T1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
FR1200581A 2012-02-28 2012-02-28 APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES Expired - Fee Related FR2987267B1 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
FR1200581A FR2987267B1 (en) 2012-02-28 2012-02-28 APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES
EP13715263.3A EP2819655B1 (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
PL13715263T PL2819655T3 (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
UAA201409664A UA113301C2 (en) 2012-02-28 2013-02-25 APPLICATION OF MODAFINIL IN THE TREATMENT OF Cocaine ADDITIONAL PATIENTS
NZ628009A NZ628009A (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
KR1020147023180A KR101897855B1 (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
IN7831DEN2014 IN2014DN07831A (en) 2012-02-28 2013-02-25
PT137152633T PT2819655T (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
ES13715263.3T ES2593276T3 (en) 2012-02-28 2013-02-25 Use of Modafinil in the treatment of cocaine addicts
DK13715263.3T DK2819655T3 (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
RS20160882A RS55238B1 (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
CN201380011342.7A CN104159575B (en) 2012-02-28 2013-02-25 Application of the modafinil in treating cocainomaniac
EA201400960A EA025692B1 (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
BR112014020626A BR112014020626A2 (en) 2012-02-28 2013-02-25 modafinil application in the treatment of cocaine lovers
LTEP13715263.3T LT2819655T (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
AU2013224831A AU2013224831B2 (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
SG11201405316WA SG11201405316WA (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
US14/381,896 US20150073055A1 (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
PCT/FR2013/000052 WO2013128088A1 (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
HUE13715263A HUE030737T2 (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
CA2863159A CA2863159C (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
MX2014010237A MX348222B (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts.
SI201330319A SI2819655T1 (en) 2012-02-28 2013-02-25 Modafinil for use in the treatment of cocaine addicts
JP2014559270A JP6163169B2 (en) 2012-02-28 2013-02-25 Use of modafinil in the treatment of cocaine addicts
ARP130100596A AR090169A1 (en) 2012-02-28 2013-02-27 APPLICATION OF MODAFINILO
TW102106817A TWI626042B (en) 2012-02-28 2013-02-27 Pharmaceutical composition of modafinil in the substitution treatment of cocaine addicts
IL234009A IL234009B (en) 2012-02-28 2014-08-07 Compositions comprising s-modafinil for use in substitution treatment of cocaine addicts
ZA2014/05910A ZA201405910B (en) 2012-02-28 2014-08-12 Use of modafinil in the treatment of cocaine addicts
PH12014501837A PH12014501837A1 (en) 2012-02-28 2014-08-14 Use of modafinil in the treatment of cocaine addicts
CL2014002203A CL2014002203A1 (en) 2012-02-28 2014-08-19 Use of modafinil in the treatment of cocaine substitution; Oral pharmaceutical composition containing Modafinil in the form of its dextrogiro enantiomer.
HRP20161165TT HRP20161165T1 (en) 2012-02-28 2016-09-12 Modafinil for use in the treatment of cocaine addicts
SM201600363T SMT201600363B (en) 2012-02-28 2016-10-12 MODAFINIL FOR USE IN THE TREATMENT OF COCAINOMANS
CY20161101079T CY1118166T1 (en) 2012-02-28 2016-10-26 MODAFINILI FOR USE IN REDUCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200581A FR2987267B1 (en) 2012-02-28 2012-02-28 APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES

Publications (2)

Publication Number Publication Date
FR2987267A1 FR2987267A1 (en) 2013-08-30
FR2987267B1 true FR2987267B1 (en) 2015-01-16

Family

ID=48083447

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1200581A Expired - Fee Related FR2987267B1 (en) 2012-02-28 2012-02-28 APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES

Country Status (33)

Country Link
US (1) US20150073055A1 (en)
EP (1) EP2819655B1 (en)
JP (1) JP6163169B2 (en)
KR (1) KR101897855B1 (en)
CN (1) CN104159575B (en)
AR (1) AR090169A1 (en)
AU (1) AU2013224831B2 (en)
BR (1) BR112014020626A2 (en)
CA (1) CA2863159C (en)
CL (1) CL2014002203A1 (en)
CY (1) CY1118166T1 (en)
DK (1) DK2819655T3 (en)
EA (1) EA025692B1 (en)
ES (1) ES2593276T3 (en)
FR (1) FR2987267B1 (en)
HR (1) HRP20161165T1 (en)
HU (1) HUE030737T2 (en)
IL (1) IL234009B (en)
IN (1) IN2014DN07831A (en)
LT (1) LT2819655T (en)
MX (1) MX348222B (en)
NZ (1) NZ628009A (en)
PH (1) PH12014501837A1 (en)
PL (1) PL2819655T3 (en)
PT (1) PT2819655T (en)
RS (1) RS55238B1 (en)
SG (1) SG11201405316WA (en)
SI (1) SI2819655T1 (en)
SM (1) SMT201600363B (en)
TW (1) TWI626042B (en)
UA (1) UA113301C2 (en)
WO (1) WO2013128088A1 (en)
ZA (1) ZA201405910B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055404B (en) * 2015-08-19 2017-07-18 四川大学 Purposes of the HMGCS2 inhibitor in the medicine for preparing treatment cocaine habituation
CN105055412B (en) * 2015-08-20 2018-06-19 四川大学 Purposes of the NAMPT inhibitor in the drug for preparing treatment cocaine habituation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (en) 1997-11-19 2000-02-18 Inst Curie USE OF BENZHYDRYL SULFINYL DERIVATIVES FOR THE MANUFACTURE OF MEDICINAL PRODUCTS HAVING A WAKING EFFECT IN SITUATIONS OF DRUG-BASED VIGILANCE DISORDERS
US20010034373A1 (en) 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
EP1330244B1 (en) * 2000-10-11 2008-12-17 Cephalon, Inc. Compositions comprising modafinil compounds
US20040006532A1 (en) 2001-03-20 2004-01-08 David Lawrence Network access risk management
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US7093476B2 (en) 2004-09-15 2006-08-22 Ut-Battelle, Llc Method for fabricating thin californium-containing radioactive source wires
WO2007013962A2 (en) * 2005-07-21 2007-02-01 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
BRPI0714173A2 (en) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd stable nanoparticulate composition, methods for preparing the composition, for preventing and / or treating disease conditions, symptoms, syndromes and conditions of the central nervous system, for improving or maintaining bioavailability of modafinil, and for treating neurologically based disorder, pharmaceutical composition, and dosage form
EP1980240A1 (en) * 2007-04-11 2008-10-15 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil

Also Published As

Publication number Publication date
FR2987267A1 (en) 2013-08-30
CA2863159C (en) 2018-06-12
DK2819655T3 (en) 2016-11-28
ES2593276T3 (en) 2016-12-07
EA025692B1 (en) 2017-01-30
TW201340964A (en) 2013-10-16
NZ628009A (en) 2015-07-31
IL234009B (en) 2018-01-31
RS55238B1 (en) 2017-02-28
KR101897855B1 (en) 2018-09-12
AU2013224831A1 (en) 2014-08-21
CY1118166T1 (en) 2017-06-28
EP2819655A1 (en) 2015-01-07
WO2013128088A1 (en) 2013-09-06
SI2819655T1 (en) 2016-11-30
LT2819655T (en) 2016-10-25
MX2014010237A (en) 2015-07-17
AU2013224831B2 (en) 2017-05-11
AR090169A1 (en) 2014-10-22
BR112014020626A2 (en) 2017-06-27
CL2014002203A1 (en) 2015-04-10
WO2013128088A8 (en) 2014-09-12
SG11201405316WA (en) 2014-11-27
CN104159575B (en) 2018-09-04
JP2015508805A (en) 2015-03-23
IN2014DN07831A (en) 2015-04-24
ZA201405910B (en) 2017-04-26
KR20140135162A (en) 2014-11-25
PH12014501837A1 (en) 2014-11-10
CN104159575A (en) 2014-11-19
PL2819655T3 (en) 2017-01-31
TWI626042B (en) 2018-06-11
UA113301C2 (en) 2017-01-10
MX348222B (en) 2017-06-05
CA2863159A1 (en) 2013-09-06
JP6163169B2 (en) 2017-07-12
IL234009A0 (en) 2014-09-30
EP2819655B1 (en) 2016-07-27
HUE030737T2 (en) 2017-05-29
PT2819655T (en) 2016-10-14
EA201400960A1 (en) 2014-12-30
SMT201600363B (en) 2016-11-10
HRP20161165T1 (en) 2016-11-04
US20150073055A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
HK1222552A1 (en) Sobetirome in the treatment of myelination diseases
DK2919796T3 (en) USE OF AKKERMANSIA FOR THE TREATMENT OF METABLE DISEASES
BR112015003227A2 (en) clicoconjugation processes and compositions
SG11201406408RA (en) Purification of biological molecules
EP2831001A4 (en) Water treatment compositions and methods of use
BR112014031223A2 (en) polymer treatment compositions
BR112013024401A2 (en) Methods and Compositions for the Treatment of Attention Deficit Disorder
DK2827813T3 (en) COLD TREATMENT DEVICE
BR112014031086A2 (en) treatment and prevention of cardiovascular disease and thrombosis
GB201506561D0 (en) Treatment of amblyopia
FR20C1044I2 (en) TRIAZINES FOR THE TREATMENT OF PROTOZOIC INFECTIONS
FR2977489B1 (en) METHODS OF COSMETIC TREATMENT AND KIT
DK2892556T3 (en) Compositions and methods for the treatment of diseases
FR2995777B1 (en) METHOD OF CHARACTERIZING THE VOLUMES OF THE SKIN
DK2688588T3 (en) QUICK AND LONG-TERM EFFECTIVE IMMUNOLOGICAL THERAPEUTIC AGENT
DK2646039T3 (en) COMPOSITION AND ITS APPLICATION IN THE TREATMENT OF ANAL RHADA
FR3015285B1 (en) FORMULATION FOR THE TREATMENT OF HAIR
FR3000491B1 (en) COMPOUNDS FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS
FR2993564B1 (en) IMIDAZOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DIABETES
DK2950918T3 (en) PROCESS UNIT AND USE OF SEVERAL PROCESS UNITS
FR2987267B1 (en) APPLICATION OF MODAFINIL IN THE TREATMENT OF SUBSTITUTION OF CACANOMANES
BR112013023115A2 (en) hair treatment composition
DK2694056T3 (en) THERAPEUTIC TREATMENT
ITRM20120473A1 (en) USE OF GLYCEROPHOSPHOINOSITOLS FOR THE TREATMENT OF SEPTIC SHOCK
FR3000399B1 (en) TOPICAL USE OF LAROPIPRANT FOR THE TREATMENT OF ROSACEA

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20181031